Table 1 Patient characteristics
From: Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
Tumor MMP-9 | P | ||
|---|---|---|---|
No ExpressionN(%) | ExpressionN(%) | ||
Age | 0.820 | ||
Below median | 137 (53.5) | 88 (54.7) | |
Above median | 119 (46.5) | 73 (45.3) | |
Sex | 0.099 | ||
Male | 179 (69.9) | 100 (62.1) | |
Female | 77 (30.1) | 61 (37.9) | |
Histology | 0.001 | ||
Squamous cell | 130 (50.8) | 45 (28.0) | |
Adenocarcinoma | 103 (40.2) | 99 (61.5) | |
Large cell | 11 (4.3) | 9 (5.5) | |
Others | 12 (4.7) | 8 (5.0) | |
Stage | 0.001 | ||
I | 158 (61.7) | 77 (47.8) | |
II | 70 (27.4) | 51 (31.7) | |
IIIA | 28 (10.9) | 33 (20.5) | |
T stage | 0.068 | ||
T1 | 75 (29.3) | 33 (20.5) | |
T2 | 147 (57.4) | 105 (65.2) | |
T3 | 32 (12.5) | 18 (11.2) | |
T4 | 2 (0.8) | 5 (3.1) | |
N stage | 0.002 | ||
N0 | 204 (79.7) | 108 (67.1) | |
N1 | 35 (13.7) | 30 (18.6) | |
N2 | 17 (6.6) | 23 (14.3) | |
Lymphovascular invasion | 0.549 | ||
No | 224 (87.5) | 144 (89.4) | |
Yes | 32 (12.5) | 17 (10.6) | |
Postoperative Treatment | 0.000 | ||
Chemotherapy | 73 (28.5) | 71 (44.1) | |
Radiation therapy | 7 (2.7) | 2 (1.2) | |
Combination therapy | 19 (7.4) | 20 (12.4) | |
No treatment | 157 (61.3) | 68 (42.2) | |